BBJ editor Don Seiffert talks about Tokai Pharmaceuticals’ soaring IPO.
There's lots of money moving around in the biotech field in Massachusetts.
According to the Boston Business Journal, Tokai Pharmaceuticals shares soared after a $98 million IPO.
BBJ editor Don Seiffert said there have been 14 biotech companies so far with IPOs, another one rolling its IPO out this week and three more before the end of the year.
"If you think about it, that's 20 percent of the total biotech IPOs in the whole country are right here in the state," he said.
